Cefdinir
- Product NDC
- 0093-4137
- 11-digit product format
- 000934137
- Labeler code
- 0093
- Product ID
- 0093-4137_7f269e55-b085-4315-807a-e425f0189b2c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefdinir
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA065332
- Marketing category
- ANDA
- Marketing start
- 2007-05-08
- Substance
- CEFDINIR MONOHYDRATE
- Active strength
- 250 mg/5mL
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cefdinir
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEFDINIR MONOHYDRATE | 250 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6E7SN358SE |
| Rxcui | 309054, 476576 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0093-4137-64 | Cefdinir | 60 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 60 | | 15 |
| 0093-4137-73 | Cefdinir | 100 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 100 | | 15 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CEFDINIR MONOHYDRATE | ACTIVE INGREDIENT | 6E7SN358SE | CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC] | 7 | |
| CEFDINIR | ACTIVE MOIETY | CI0FAO63WC | CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC] | 7 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC] | 7 | |
| ANHYDROUS TRISODIUM CITRATE | INACTIVE INGREDIENT | RS7A450LGA | CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC] | 7 | |
| GUAR GUM | INACTIVE INGREDIENT | E89I1637KE | CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC] | 7 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC] | 7 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC] | 7 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC] | 7 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC] | 7 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC] | 7 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0093-4137 | CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA, INC.] | 15 | Current NDC, Legacy NDC, 2 package rows | 20240305_a1f49fe1-b511-4f6b-a912-8ae8662d95a5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-4137-64 | 00093413764 | 60 mL in 1 BOTTLE (0093-4137-64) | 60 ml | 2007-05-08 | 0000-00-00 | No | No | Current |
| 0093-4137-73 | 00093413773 | 100 mL in 1 BOTTLE (0093-4137-73) | 100 ml | 2007-05-08 | 0000-00-00 | No | No | Current |